Open Access

Poster session 3 - Chronic pulmonary hypertension

Event: ESC CONGRESS 2016
Topic: Miscellaneous
Session type: Poster Session
Date: 28 August 2016

Session

16 presentations in this session

Experience in the pulmonary arterial hypertension management over 30 years: insights of a national reference center.

Speaker: Doctor C. Quezada-Loaiza (Madrid, ES)
Thumbnail

Lung transplantation for pulmonary arterial hypertension, the multidisciplinary approach from an expert center.

Speaker: Doctor C. Quezada-Loaiza (Madrid, ES)
Thumbnail

Factors prohibiting progression to prostanoid therapy in patients with pulmonary arterial hypertension and CTEPH who remain in functional class III or above despite maximal oral therapy

Speaker: Doctor H. Nashat (London, GB)
Thumbnail

Effects of sildenafil in patients with persistent pulmonary hypertension after left prosthetic valvular replacement at rest and during dobutamine stress according to the hemodynamic phenotype

Speaker: Associate Professor J. Aguilar Torres (Madrid, ES)
Thumbnail

Initial combination with bosentan and sildenafil as compared with initial monotherapy with the same drugs in patients with pulmonary arterial hypertension: a case-control, multicentre study

Speaker: Doctor M. Palazzini (Bologna, IT)
Thumbnail

Effect of calcium channel blockers on exercise capacity in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing

Speaker: Mr Y. Tang (Beijing, CN)
Thumbnail

Ablation of supraventricular arrhythmias in patients with pulmonary hypertension

Speaker: Doctor Y. Qi (Beijing, CN)
Thumbnail

Pharmacokinetic interactions in different combinations of specific pulmonary arterial hypertension treatment

Speaker: Ms S. Harutyunova (Heidelberg, DE)
Thumbnail

Change of sildenafil plasma concentrations after transition from bosentan to macitentan in pulmonary arterial hypertension

Speaker: Ms S. Harutyunova (Heidelberg, DE)
Thumbnail

Von Willebrand factor multimer disruption as a biological sensor of pulmonary hypertension severity

Speaker: Doctor J. Ray (Jacksonville, US)
Thumbnail

15 speakers from this session

Doctor Carlos Andres Quezada-Loaiza

University Hospital 12 de Octubre, Madrid (Spain)
0 follower

Doctor Carlos Andres Quezada-Loaiza

University Hospital 12 de Octubre, Madrid (Spain)
0 follower

Doctor Hebah Nashat

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Associate Professor Jorge Aguilar Torres

University Hospital of La Princesa, Madrid (Spain)
0 follower

Doctor Massimiliano Palazzini

Institute of Cardiology, University of Bologna, Bologna (Italy)
0 follower

Mr Yi Tang

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (China)
0 follower

Doctor Yingjie Qi

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (China)
0 follower

Ms Satenik Harutyunova

Thoraxclinic of Heidelberg, Heidelberg (Germany)
0 follower

Ms Satenik Harutyunova

Thoraxclinic of Heidelberg, Heidelberg (Germany)
0 follower

Doctor Jordan Ray

Mayo Clinic, Jacksonville (United States of America)
0 follower

Associate Professor Hakuoh Konishi

Juntendo University, Department of Cardiology, Tokyo (Japan)
0 follower

Doctor Hidekazu Maruyama

National Hospital Organization Kasumigaura Medical Center, Tsuchiura (Japan)
0 follower

Doctor Remigiusz Kazimierczyk

Medical University of Bialystok, Bialystok (Poland)
0 follower

Doctor Els Vandecasteele

University Hospital Ghent, Gent (Belgium)
0 follower

Doctor Rong Jiang

Shanghai Pulmonary Hospital of Tongji University Medical School, Dept of Pulmonary Circulation, Shanghai (China)
0 follower

This platform is supported by

logo Novo Nordisk